PL3331517T3 - Zastosowanie hydroksymocznika w celu zapobiegania brakowi perfuzji w siatkówce - Google Patents

Zastosowanie hydroksymocznika w celu zapobiegania brakowi perfuzji w siatkówce

Info

Publication number
PL3331517T3
PL3331517T3 PL16750804T PL16750804T PL3331517T3 PL 3331517 T3 PL3331517 T3 PL 3331517T3 PL 16750804 T PL16750804 T PL 16750804T PL 16750804 T PL16750804 T PL 16750804T PL 3331517 T3 PL3331517 T3 PL 3331517T3
Authority
PL
Poland
Prior art keywords
hydroxycarbamide
perfusion
preventing retinal
retinal non
preventing
Prior art date
Application number
PL16750804T
Other languages
English (en)
Inventor
Yves Colin
Jean-François GIRMENS
Olivier Hermine
Emmanuel Heron
Michel Paques
Original Assignee
Centre Hospitalier National D'ophtalmologie Quinze-Vingts
Institut National De La Santé Et De La Recherche Médicale (Inserm)
Centre National De La Recherche Scientifique (Cnrs)
Imagine Institut Des Maladies Génétiques Necker Enfants Malades
Assistance Publique - Hôpitaux De Paris
Université Paris Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Hospitalier National D'ophtalmologie Quinze-Vingts, Institut National De La Santé Et De La Recherche Médicale (Inserm), Centre National De La Recherche Scientifique (Cnrs), Imagine Institut Des Maladies Génétiques Necker Enfants Malades, Assistance Publique - Hôpitaux De Paris, Université Paris Descartes filed Critical Centre Hospitalier National D'ophtalmologie Quinze-Vingts
Publication of PL3331517T3 publication Critical patent/PL3331517T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL16750804T 2015-08-06 2016-08-08 Zastosowanie hydroksymocznika w celu zapobiegania brakowi perfuzji w siatkówce PL3331517T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15306277 2015-08-06
EP16750804.3A EP3331517B1 (fr) 2015-08-06 2016-08-08 Utilisation d'hydroxycarbamide pour prevenir la non-perfusion retinienne
PCT/EP2016/068908 WO2017021560A1 (fr) 2015-08-06 2016-08-08 Utilisation d'hydroxycarbamide pour prevenir la non-perfusion retinienne

Publications (1)

Publication Number Publication Date
PL3331517T3 true PL3331517T3 (pl) 2020-06-29

Family

ID=53836030

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16750804T PL3331517T3 (pl) 2015-08-06 2016-08-08 Zastosowanie hydroksymocznika w celu zapobiegania brakowi perfuzji w siatkówce

Country Status (6)

Country Link
US (1) US10617658B2 (pl)
EP (1) EP3331517B1 (pl)
ES (1) ES2770698T3 (pl)
PL (1) PL3331517T3 (pl)
PT (1) PT3331517T (pl)
WO (1) WO2017021560A1 (pl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7008960B1 (en) * 1999-03-02 2006-03-07 Vitreo-Retinal Technologies, Inc. Agents for intravitreal administration to treat or prevent disorders of the eye
US6462071B1 (en) * 2000-03-02 2002-10-08 Vitreo-Retinal Technologies, Inc. Agents for intravitreal administration to treat or prevent disorders of the eye
AU780299B2 (en) * 1999-03-02 2005-03-17 Numoda Biotechnologies, Inc. Agents for intravitreal administration to treat or prevent disorders of the eye
CA2572223C (en) * 2004-06-25 2014-08-12 The Johns Hopkins University Angiogenesis inhibitors
US20140171504A1 (en) * 2012-12-14 2014-06-19 Georgia Regents Research Institute, Inc. Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters

Also Published As

Publication number Publication date
EP3331517B1 (fr) 2019-11-06
ES2770698T3 (es) 2020-07-02
WO2017021560A1 (fr) 2017-02-09
US20180221313A1 (en) 2018-08-09
US10617658B2 (en) 2020-04-14
PT3331517T (pt) 2020-02-18
EP3331517A1 (fr) 2018-06-13

Similar Documents

Publication Publication Date Title
SG11201706729SA (en) Derivatives of sobetirome
IL253945A0 (en) kdm1a inhibitors to treat the disease
IL259281B (en) History of bipyrazolyl used in the treatment of autoimmune diseases
SG11201609652RA (en) Treatment of polybacterials infections
IL250732A0 (en) Mixtures for photodynamic control of pollution
ZA201701644B (en) Therapeutic compounds as inhibitors of the orexin-1 receptor
SMT202100551T1 (it) Derivati di sobetirome
IL249502A0 (en) Novel therapeutic uses of benzylideneguanidine derivatives for the treatment of protein-associated diseases
IL285882A (en) Medicinal uses for l–4–chlorokynurenine
ZA201705708B (en) Inhibition of olig2 activity
PT3142641T (pt) Formulações para o tratamento de hipertiroidismo
ZA201800163B (en) New anti-malarial agents
LT3389638T (lt) Farmacinė kompozicija, kurios sudėtyje yra pimobendano
EP3091985A4 (en) Treatment of migraines
PL3484875T3 (pl) Pochodne pirazoliloaminobenzimidazolu jako inhibitory JAK
GB201412010D0 (en) Treatment of hypertransaminasemia
PL3331517T3 (pl) Zastosowanie hydroksymocznika w celu zapobiegania brakowi perfuzji w siatkówce
ZA201703153B (en) Purification of polyphenols
HUP1400518A2 (hu) Eljárás tofacitinib elõállítására
GB201512635D0 (en) Uses of therapeutic compounds
GB201607437D0 (en) New use of pemirolast
GB201607438D0 (en) New use of pemirolast
GB201522706D0 (en) Treatments of central nervous system conditions
GB201504413D0 (en) Treatment of disease
GB201403170D0 (en) Preparation of antibacterial bisbenzimidazoles